Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 2/20 | 0.44 |
| ▸ | TRHR | P34981 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 6/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27905689 | 1.00 | OPRK1 (0.44) | OPRK1TRHRHDAC3HDAC11HDAC6 | |
| SCHEMBL159688 | 1.00 | OPRK1 (0.44) | OPRK1TRHRHDAC3HDAC11HDAC6 | |
| SCHEMBL31061201 | 0.91 | OPRK1 (0.45) | OPRK1TRHRHDAC3HDAC11HDAC6 | |
| SCHEMBL22319323 | 0.89 | FOLH1 (0.46) | TRHRHDAC3HDAC11HDAC6HDAC1 | |
| SCHEMBL22319322 | 0.89 | FOLH1 (0.46) | TRHRHDAC3HDAC11HDAC6HDAC1 | |
| SCHEMBL11173161 | 0.89 | FOLH1 (0.46) | TRHRHDAC3HDAC11HDAC6HDAC1 | |
| SCHEMBL11246319 | 0.88 | OPRK1 (0.49) | OPRK1HDAC3HDAC11HDAC6HDAC1 | |
| SCHEMBL31199140 | 0.88 | OPRK1 (0.41) | OPRK1TRHRHDAC3HDAC11HDAC6 | |
| SCHEMBL29713552 | 0.87 | OPRK1 (0.46) | OPRK1TRHRHDAC3HDAC11HDAC6 | |
| SCHEMBL29416863 | 0.87 | OPRK1 (0.46) | OPRK1TRHRHDAC3HDAC11HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120041530-A | Glutamine peptide with activity of improving alcoholic gastric mucosal injury as well as preparation method and application thereof | 中国食品发酵工业研究院有限公司 | 2025-05-27 | — | — | CN | claimed |
| US-20240315296-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | CJ CHEILJEDANG CORPORATION (KR) | 2024-09-26 | — | — | US | claimed |
| EP-4364582-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | CJ Cheiljedang Corporation (KR) | 2024-05-08 | — | — | EP | claimed |
| CN-117677302-A | Peptide compounds for flavor modulation | CJ第一制糖株式会社 | 2024-03-08 | — | — | CN | claimed |
| WO-2023277549-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | 씨제이제일제당 (주) | 2023-01-05 | — | — | WO | claimed |
| US-20130224855-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | FRIESLANDCAMPINA NEDERLAND HOLDING B.V. (NL) | 2013-08-29 | — | — | US | claimed |
| EP-0973518-B1 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | UNIV ILLINOIS (US) | 2006-03-29 | — | — | EP | claimed |
| EP-0973518-A4 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | UNIV ILLINOIS (US) | 2004-05-26 | — | — | EP | claimed |
| US-20020037835-A1 | Semi-synthetic studies toward didemnin analogues | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, THE | 2002-03-28 | — | — | US | claimed |
| US-20010007855-A1 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, THE | 2001-07-12 | — | — | US | claimed |
| EP-0973518-A1 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2000-01-26 | — | — | EP | claimed |
| WO-1998017275-A1 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1998-04-30 | — | — | WO | claimed |
| US-20250268291-A1 | FLAVOR COMPOSITIONS AND SCREENING METHODS FOR IDENTIFYING THE SAME | MARS, INCORPORATED (US) | 2025-08-28 | — | — | US | disclosed |
| US-12317911-B2 | Flavor compositions and screening methods for identifying the same | MARS, INCORPORATED (US) | 2025-06-03 | — | — | US | disclosed |
| CN-120041530-A | Glutamine peptide with activity of improving alcoholic gastric mucosal injury as well as preparation method and application thereof | 中国食品发酵工业研究院有限公司 | 2025-05-27 | — | — | CN | disclosed |
| EP-3768092-B1 | FLAVOR COMPOSITIONS AND METHODS FOR PREPARING THE SAME | MARS INC (US) | 2024-10-02 | — | — | EP | disclosed |
| US-20020037835-A1 | Semi-synthetic studies toward didemnin analogues | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, THE | 2002-03-28 | — | — | US | disclosed |
| US-20010007855-A1 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, THE | 2001-07-12 | — | — | US | disclosed |
| EP-0973518-A1 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998017275-A1 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1998-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010007855-A1 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | FAR1, FASN, GOT1 | OPRK1 142/4885TRHR 1651/4885HDAC3 3425/4885 |
| US-20020037835-A1 | Semi-synthetic studies toward didemnin analogues | FAR1, FASN, GOT1 | OPRK1 142/4885TRHR 1651/4885HDAC3 3425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.